CIK 0000875320
VRTX VERTEX PHARMACEUTICALS INC / MA
Insider trading from SEC Form 4. Last filing Nov 19, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company
Signals
Open-market buys and sells at VERTEX PHARMACEUTICALS INC / MA, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 0Weak | sell10b5-1 | ALTSHULER DAVID EVP, Chief Scientific Officer | $7,178 | 15 | -0% | - |
Congressional trades
14 trades in VRTX disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| David J. Taylor House · R-OH | Sale | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Aug 26, 2026 | 10 days after the trade |
| Tommy Tuberville Senate · R-AL | Sale | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | May 3, 2024 | 824 days after the trade |
| Alan Armstrong Senate · R-OK | Purchase | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| David J. Taylor House · R-OH | Sale | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Jan 29, 2026 | 4 days after the trade |
| Julia Letlow House · R-LA | Purchase | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Oct 23, 2024 | 447 days after the trade |
| David J. Taylor House · R-OH | Purchase | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Aug 7, 2025 | 26 days after the trade |
| Lisa C. McClain House · R-MI | Purchase | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Dec 11, 2024 | 245 days after the trade |
| Lisa C. McClain House · R-MI | Sale | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Jun 11, 2025 | 63 days after the trade |
| Lisa C. McClain House · R-MI | Partial sale | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Jun 10, 2025 | 64 days after the trade |
| Jefferson Shreve House · R-IN | Sale | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $15k to $50k | May 12, 2025 | 41 days after the trade |
| Byron Donalds House · R-FL | Sale | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Mar 20, 2025 | 25 days after the trade |
| Byron Donalds House · R-FL | Sale | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $1,001 to $15k | Mar 20, 2025 | 25 days after the trade |
| Jefferson Shreve House · R-IN | Purchase | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $15k to $50k | Mar 13, 2025 | 29 days after the trade |
| Jefferson Shreve House · R-IN | Purchase | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $15k to $50k | Feb 24, 2025 | 13 days after the trade |
Transactions
The last 1 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | ALTSHULER DAVID EVP, Chief Scientific Officer | SOpen-market sale Common Stock10b5-1 | -15 | $478.56 | $7,178 | 25,813 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.